Read More

Wells Fargo Analyst Sees Opportunity For Homebuilding & Building Product Companies Amid Volatility: The Details

Wells Fargo analyst Sam Reid initiated coverage on several homebuilding and building products stocks. The analyst said recent volatility in the homebuilding space offers an opportunity. Reid cites that the high rates pose a barrier for resales but offer interesting TAM implications amid low existing home sales (EHS) builders. 

DHI

Read More

Cautious Optimism For Bluebird Bio’s Sickle Cell Therapy: Analyst Sees Financial Challenges

Cantor Fitzgerald initiated coverage on Bluebird Bio Inc (NASDAQ: BLUE), saying sickle cell disorder (SCD) has been a hotbed of development for genetic medicines as the company's lovo-cel marches towards the U.S. market. 

BLUE